CD5 deletion enhances the antitumor activity of adoptive T cell therapiesRuchi P. Patel, Patrizia Porazzi, Guido Ghilardi et al.|Science Immunology|2024Cited by 45
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphomaKeisuke Watanabe, Carl H. June, Angela M. Gomez et al.|Blood Advances|2023Cited by 43
Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2Nicola J. Mason, Amy K. LeBlanc, J. Matthew Mahoney et al.|Molecular Therapy|2025Cited by 10